Pradelli L, Di Perri G, Rizzardini G, et al. A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context. Farmeconomia. Health Economics and Therapeutic Pathways. 2017;18(1). https://doi.org/10.7175/fe.v18i1.1312